IMMUNOVANT INC's ticker is IMVT and the CUSIP is 45258J102. A total of 121 filers reported holding IMMUNOVANT INC in Q4 2021. The put-call ratio across all filers is 0.09 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $239,290,475 | +130.7% | 6,233,146 | +14.0% | 0.01% | +200.0% |
| Q2 2023 | $103,739,646 | +30.0% | 5,468,616 | +6.3% | 0.00% | 0.0% |
| Q1 2023 | $79,778,926 | -11.3% | 5,143,709 | +1.5% | 0.00% | 0.0% |
| Q4 2022 | $89,976,862 | +303.1% | 5,069,119 | +26.7% | 0.00% | +100.0% |
| Q3 2022 | $22,322,000 | +43.1% | 4,000,450 | +0.0% | 0.00% | – |
| Q2 2022 | $15,597,000 | -24.8% | 3,999,493 | +6.2% | 0.00% | – |
| Q1 2022 | $20,750,000 | -36.5% | 3,765,713 | -1.8% | 0.00% | -100.0% |
| Q4 2021 | $32,667,000 | +0.3% | 3,834,119 | +2.3% | 0.00% | 0.0% |
| Q3 2021 | $32,581,000 | -23.0% | 3,749,286 | -6.3% | 0.00% | 0.0% |
| Q2 2021 | $42,288,000 | -34.0% | 4,000,697 | +0.1% | 0.00% | -50.0% |
| Q1 2021 | $64,107,000 | -64.2% | 3,996,720 | +3.0% | 0.00% | -60.0% |
| Q4 2020 | $179,150,000 | +60.1% | 3,878,549 | +21.9% | 0.01% | +25.0% |
| Q3 2020 | $111,927,000 | +172.0% | 3,180,644 | +88.2% | 0.00% | +300.0% |
| Q2 2020 | $41,155,000 | – | 1,690,114 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alpine Global Management, LLC | 3,000,200 | $26,072,000 | 5.92% |
| MANGROVE PARTNERS IM, LLC | 1,139,900 | $9,906,000 | 0.89% |
| Eventide Asset Management | 4,950,000 | $43,016,000 | 0.57% |
| Ghost Tree Capital, LLC | 200,000 | $1,738,000 | 0.51% |
| WITTENBERG INVESTMENT MANAGEMENT, INC. | 140,500 | $1,221,000 | 0.47% |
| FRAZIER MANAGEMENT LLC | 585,759 | $5,090,000 | 0.41% |
| MANGROVE PARTNERS IM, LLC | 500,000 | $4,345,000 | 0.39% |
| EcoR1 Capital, LLC | 1,140,819 | $9,914,000 | 0.34% |
| BCK CAPITAL MANAGEMENT LP | 53,459 | $465,000 | 0.28% |
| PLATINUM INVESTMENT MANAGEMENT LTD | 555,065 | $4,824,000 | 0.14% |